Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
BG Medicine Inc.
BG Medicine Inc. Launches Galectin-3 Website and Commences Galectin-3 Assay Service for Clinical Research
April 14th, 2009
BG Medicine Inc. (BGM), a developer of novel, biomarker-based diagnostic products, announced the launch of the Galectin-3 Website (www.galectin-3.com) which will provide an array of research materials associated with galectin-3. Galectins are a unique class of proteins with a relatively high affinity for specific carbohydrate compounds. Upon the tight specific binding between carbohydrate and protein, galectins display certain profound biological effects. Galectins were first described in 1994 and to date, 15 members have been identified. Accruing evidence indicates that galectins are important immunoregulatory mediators and research in the role of galectins in health...
Source: Cancer Weekly (2009-04-14)
|
